Table 1.
General characteristics of RA patients.
| RA (n = 214) | |
|---|---|
| Characteristics of the groups | |
| Sex-female (%, n) | 64.5 (138) |
| Age (years) | 58 (12) |
| Body mass index (kg/m2) | 27.8 (5.9) |
| Waist circumference (cm) | 93 (15) |
| Systolic blood pressure (mmHg) | 137 (21) |
| Diastolic blood pressure (mmHg) | 81 (12) |
| LDL cholesterol (mg/dL) | 119 (31) |
| HDL cholesterol (mg/dL) | 66 (19) |
| Triglycerides (mg/dL) | 105 (55) |
| Glucose (mg/dL) | 95 (23) |
| Current smoker (%, n) | 26.2 (56) |
| Hypertension (%, n) | 60.3 (129) |
| Diabetes mellitus (%, n) | 11.7 (25) |
| Dyslipidemia (%, n) | 41.1 (88) |
| Disease features | |
| Disease duration (years) | 9.4 (9.1) |
| DAS28 | 3.5 (1.3) |
| Disease Remission (%,n) | 27.1 (58) |
| Low disease activity (%, n) | 18.7 (41) |
| Moderate disease activity (%, n) | 44.4 (95) |
| High disease activity (%, n) | 9.8 (21) |
| HAQ | 0.45 (0.52) |
| Rheumatoid factor + (%, n) | 72.4 (155) |
| ACPA + (%, n) | 81.3 (174) |
| ESR (mm/h) | 37 (26) |
| CRP (mg/dL) | 0.72 (0.83) |
| Fibrinogen (mg/dL) | 443 (97) |
| Treatments (%, n) | |
| DMARDs | 75.2 (161) |
| Biological agent | 20.1 (43) |
| NSAIDs | 57 (122) |
| Corticosteroids | 50.9 (109) |
HAQ; health assessment questionnaire index, ACPA; citrullinated anti-cyclic peptide antibodies, ESR; erythrocyte sedimentation rate, CRP; C-reactive protein, DAS28; disease activity score, DMARDs; disease-modifying antirheumatic drugs, NSAIDs; non-steroidal anti-inflammatory drugs.